CXCL12 and prostate carcinoma: In a model of prostate cancer bone metastasis, CXCL12 expression was increased in the bone with the strongest staining observed within the endosteal region associated with osteoblasts [127], similar to osteoblast-derived CXCL12 in HSC homing [71].